dalteparin has been researched along with Anoxia, Fetal in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vianello, A | 1 |
| Vencato, E | 1 |
| Cantini, M | 1 |
| Zanconato, G | 1 |
| Manfrin, E | 1 |
| Zamo, A | 1 |
| Zorzi, F | 1 |
| Mazzi, F | 1 |
| Martinelli, N | 1 |
| Cavaliere, E | 1 |
| Monari, F | 1 |
| Venturelli, D | 1 |
| Ferrara, F | 1 |
| Olivieri, O | 1 |
| De Franceschi, L | 1 |
1 other study available for dalteparin and Anoxia, Fetal
| Article | Year |
|---|---|
Improvement of maternal and fetal outcomes in women with sickle cell disease treated with early prophylactic erythrocytapheresis.
Topics: Abortion, Spontaneous; Adult; Anemia, Sickle Cell; Anticoagulants; Birth Weight; Cross-Sectional Stu | 2018 |